Case report of an infant who developed methemoglobinemia after lidocaine/propitocaine cream application

DOI Web Site 6 References Open Access

Bibliographic Information

Other Title
  • リドカイン・プロピトカイン配合クリームにより中毒性メトヘモグロビン血症をきたした乳児例

Search this article

Description

<p>Lidocaine/propitocaine cream (EMLA® cream) is used in skin laser irradiation therapy and for pain relief arising during injection and from indwelling venous cannulae. We report the case of a 1-month-old girl who experienced methemoglobinemia after administration of this drug and required intensive care management. The symptoms improved with administration of methylthioninium, and she was discharged without neurological sequelae. To our knowledge, there are no previous reports of methemoglobinemia caused by the application of this drug in Japan. As our patient was a young infant, the cytochrome-b5 reductase activity that reduces methemoglobin was lower than that of adults, and there are easily oxidizable fetal hemoglobin. It was thought that lidocaine and propitocaine, and their metabolism caused methemoglobinemia against this background. Attention is required in the use of lidocaine/propitocaine cream for neonates and young infants, and it should be used according to age-adapted dose and application time. With the occurrence of central cyanosis that does not improve even with oxygen administration, or when there is a discrepancy between SaO2 and SpO2, it is necessary to consider methemoglobinemia.</p>

Journal

References(6)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top